This inventor holds 1 USPTO granted patent. Top assignee: Repare Therapeutics Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Cameron Black: Innovator in Pharmaceutical Chemistry
Introduction
Cameron Black is a notable inventor based in Baie-D'Urfé, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. His work focuses on creating effective treatments for various health conditions.
Latest Patents
Cameron Black holds 1 patent for his invention titled "Substituted 2-morpholinopyridine derivatives as ATR kinase inhibitors." This patent discloses compounds and pharmaceutically acceptable salts that may be utilized in treating subjects in need. The compounds are identified as inhibitors of Ataxia-telangiectasia and RAD-3-related protein kinase (ATR). Additionally, the patent includes pharmaceutical compositions containing these compounds and methods for their preparation and use.
Career Highlights
Cameron Black is currently associated with Repare Therapeutics Inc., where he applies his expertise in drug development and innovation. His work at the company emphasizes the importance of creating effective therapeutic solutions for patients.
Collaborations
Cameron collaborates with Vouy-Linh Truong, contributing to the advancement of their research and development efforts in the pharmaceutical industry.
Conclusion
Cameron Black's innovative work in pharmaceutical chemistry, particularly his patent on ATR kinase inhibitors, showcases his commitment to improving medical treatments. His contributions are vital in the ongoing quest for effective therapies.